Insider · CIK 0002032345

Jamil Khurram

Reports to the SEC for 1 company · NORCROSS, GA

sec.gov

Transactions

Companies

Filings

CIK

0002032345

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-14	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+16.3K sh	$3.04	+$49.4K	16,250
2026-07-14	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−16.3K sh	$5.13	−$83.3K	0
2026-07-14	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−16.3K sh	—	—	48,750
2026-06-29	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+47.5K sh	$2.50	+$119K	47,467
2026-06-29	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−47.5K sh	$5.04	−$239K	0
2026-06-29	GALTGALECTIN THERAPEUTICS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−47.5K sh	—	—	0
2026-06-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,037 sh	$2.20	+$4,481.4	2,037
2026-06-26	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−2,037 sh	$5.00	−$10.2K	0
2026-06-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,533 sh	$2.50	+$6,332.5	2,533
2026-06-26	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−2,533 sh	$5.00	−$12.7K	0
2026-06-26	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,037 sh	—	—	100,000
2026-06-26	GALTGALECTIN THERAPEUTICS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,533 sh	—	—	47,467
2026-06-23	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,557 sh	$1.23	+$9,295.11	7,557
2026-06-23	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−7,557 sh	$3.14	−$23.7K	0
2026-06-23	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,557 sh	—	—	32,500
2026-05-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+568 sh	$1.23	+$698.64	568
2026-05-26	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−568 sh	$3.10	−$1,761.027	0
2026-05-26	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−568 sh	—	—	40,057
2026-01-16	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	Chief Medical Officer	AAward	+65K sh	—	—	65,000
2026-01-16	GALTGALECTIN THERAPEUTICS INC · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2026-01-06	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−21.4K sh	$3.65	−$78.2K	0
2026-01-05	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−25.5K sh	$3.90	−$99.4K	21,446
2026-01-02	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+60K sh	—	—	60,000
2026-01-02	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−13.1K sh	$4.20	−$54.8K	46,945
2026-01-01	GALTGALECTIN THERAPEUTICS INC · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−60K sh	—	—	0
2025-12-31	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,125 sh	$1.23	+$9,993.75	8,125
2025-12-31	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−8,125 sh	$4.07	−$33.1K	0
2025-12-31	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,125 sh	—	—	40,625
2025-12-17	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−4,479 sh	$7.04	−$31.5K	0
2025-12-17	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,463 sh	$2.20	+$14.2K	6,463
2025-12-17	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−6,463 sh	$7.04	−$45.5K	0
2025-12-17	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,500 sh	$2.50	+$21.3K	8,500
2025-12-17	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−8,500 sh	$7.04	−$59.8K	0
2025-12-17	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,463 sh	—	—	102,037
2025-12-17	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,500 sh	—	—	50,000
2025-11-13	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−21.9K sh	$5.47	−$120K	4,479
2025-11-13	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+41.5K sh	$2.20	+$91.3K	45,979
2025-11-13	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−41.5K sh	$5.47	−$227K	4,479
2025-11-13	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+41.5K sh	$2.50	+$104K	45,979
2025-11-13	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−41.5K sh	$5.47	−$227K	4,479
2025-11-13	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+16.3K sh	$1.23	+$20K	20,729
2025-11-13	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−16.3K sh	$5.47	−$88.9K	4,479
2025-11-13	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−41.5K sh	—	—	108,500
2025-11-13	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−41.5K sh	—	—	58,500
2025-11-13	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−16.3K sh	—	—	48,750
2025-01-23	GALTGALECTIN THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+65K sh	—	—	65,000
2025-01-23	GALTGALECTIN THERAPEUTICS INC · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2024-12-23	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+40K sh	—	—	40,000
2024-12-23	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−13.7K sh	$0.88	−$12K	26,346
2024-12-23	GALTGALECTIN THERAPEUTICS INC · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+40K sh	—	—	0

Recent filings

Accepted (ET)
Jul 164
Jamil Khurram0001133416-26-000063
SEC(opens sec.gov)
Jun 304
Jamil Khurram0001133416-26-000059
SEC(opens sec.gov)
Jun 254
Jamil Khurram0001133416-26-000057
SEC(opens sec.gov)
May 284
Jamil Khurram0001133416-26-000055
SEC(opens sec.gov)
Jan 214
Jamil Khurram0001133416-26-000038
SEC(opens sec.gov)

Companies

GALECTIN THERAPEUTICS INCChief Medical OfficerGALT

Address

4960 PEACHTREE INDUSTRIAL BLVD SUITE 240

NORCROSS, GA, 30071